Medicare Enrolled
Dr. Edward Federman, M.D.
Critical Care Medicine · San Diego, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Federman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Federman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Federman
Dr. Edward Federman is a critical care medicine specialist in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Federman performed 1,912 Medicare services across 1,084 unique beneficiaries.
Between the years covered by Open Payments, Dr. Federman received a total of $7,983 from 38 pharmaceutical and/or device companies across 277 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Federman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in CA
$7,983 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,912
Medicare services
Top 15% in CA for critical care medicine
1,084
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~101 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
810 | $104 | $225 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
392 | $34 | $160 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
205 | $63 | $150 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
73 | $33 | $35 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
64 | $10 | $20 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
61 | $70 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $134 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
41 | $11 | $30 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
30 | $15 | $35 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
30 | $9 | $24 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
29 | $108 | $420 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
22 | $3 | $12 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
18 | $282 | $300 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
18 | $33 | $35 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
13 | $28 | $69 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $140 | $275 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 12 | $20 | $30 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
11 | $39 | $150 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
11 | $52 | $110 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,983
Total received (2018-2024)
Avg $1,140/year across 7 years
Top 16% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
277
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,762 (84.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$900 (11.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$321 (4.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,157
2023
$1,071
2022
$1,086
2021
$1,556
2020
$443
2019
$2,098
2018
$572
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$324
AstraZeneca Pharmaceuticals LP
$255
Grifols USA, LLC
$89
Insmed, Inc.
$79
Actelion Pharmaceuticals US, Inc.
$79
Mylan Specialty L.P.
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
GENZYME CORPORATION
$44
Regeneron Healthcare Solutions, Inc.
$29
Shionogi Inc
$25
Paratek Pharmaceuticals, Inc.
$24
Octapharma USA, Inc.
$24
PFIZER INC.
$24
Seqirus USA Inc
$24
Phadia US Inc.
$18
Electronic Waveform Lab, Inc.
$12
Top 3 companies account for 57.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,787
AstraZeneca UK Limited
$1,490
Medtronic, Inc.
$900
AstraZeneca Pharmaceuticals LP
$846
Boehringer Ingelheim Pharmaceuticals, Inc.
$446
PFIZER INC.
$257
Insmed, Inc.
$257
Actelion Pharmaceuticals US, Inc.
$209
Merck Sharp & Dohme Corporation
$187
Astellas Pharma US Inc
$165
GENZYME CORPORATION
$151
Grifols USA, LLC
$143
Gilead Sciences, Inc.
$133
Regeneron Healthcare Solutions, Inc.
$130
Mylan Specialty L.P.
$123
SANOFI-AVENTIS U.S. LLC
$77
Electromed, Inc.
$71
Paratek Pharmaceuticals, Inc.
$71
Genentech USA, Inc.
$60
Sunovion Pharmaceuticals Inc.
$53
SANOFI PASTEUR INC.
$46
Melinta Therapeutics, LLC
$41
Philips Electronics North America Corporation
$37
Melinta Therapeutics, Inc.
$35
Baxter Healthcare
$26
Shionogi Inc
$25
Octapharma USA, Inc.
$24
Seqirus USA Inc
$24
Harmony Biosciences LLC
$23
BOSTON SCIENTIFIC CORPORATION
$23
Phadia US Inc.
$18
Circassia Pharmaceuticals Inc
$16
JAZZ PHARMACEUTICALS INC.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
Sanofi Pasteur Inc.
$15
Janssen Pharmaceuticals, Inc
$15
Resmed Corp
$14
Electronic Waveform Lab, Inc.
$12
Top 3 companies account for 52.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · ACQUIRE · ADACEL · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Arikayce · Astral · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CUTAQUIG · Cresemba · DIFICID · DUPIXENT · ELIQUIS · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · Fetroja · Fluad · GLASSIA · Hillrom - Life 2000 Ventilation System · ImmunoCAP · Kimyrsa · LONHALA MAGNAIR · NOXAFIL · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolastin-C Liquid · Puritan Bennett · Rezzayo · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · UPTRAVI · Vabomere · Wakix · XARELTO · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
80
Per 100K population
2.4
County median income
$102,285
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN DIEGO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Federman is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Federman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Federman performed 810 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Federman receive payments from pharmaceutical companies?
Yes. Dr. Federman received a total of $7,983 from 38 companies across 277 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Federman's costs compare to other critical care medicines in San Diego?
Dr. Federman's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Federman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in San Diego
Browse critical care medicines in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca UK Limited Payments to Doctors
See all physicians who received payments from AstraZeneca UK Limited.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology